<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by sandip kumar on Medium]]></title>
        <description><![CDATA[Stories by sandip kumar on Medium]]></description>
        <link>https://medium.com/@sandipkumar38491?source=rss-c5d19b311dc4------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/0*u-XXmLUvlOVV5bgN.jpg</url>
            <title>Stories by sandip kumar on Medium</title>
            <link>https://medium.com/@sandipkumar38491?source=rss-c5d19b311dc4------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Fri, 20 Nov 2026 09:03:53 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@sandipkumar38491/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Orthopedic Implants Market Size, Share and Trends Analysis 2030]]></title>
            <link>https://sandipkumar38491.medium.com/orthopedic-implants-market-size-share-and-trends-analysis-2030-94a53a429871?source=rss-c5d19b311dc4------2</link>
            <guid isPermaLink="false">https://medium.com/p/94a53a429871</guid>
            <dc:creator><![CDATA[sandip kumar]]></dc:creator>
            <pubDate>Tue, 06 Sep 2022 05:31:11 GMT</pubDate>
            <atom:updated>2022-09-06T05:31:11.533Z</atom:updated>
            <content:encoded><![CDATA[<p><strong>Orthopedic Implants Market Overview</strong></p><p>The growing prevalence of orthopedic conditions as increase in patients suffering from fractures, arthritis, and osteoporosis, creating the demand for orthopedic implants can support expansion of the market. The rise in demand for osseointegration implants in veterinary hospitals clinics can support rise of the market in the assessment period.</p><p>Market Research Future (MRFR) assessed the global <a href="https://www.marketresearchfuture.com/reports/orthopedic-implant-market-838">orthopedic implants market</a> size is expand at 4.71% CAGR By 2030, the orthopedic implants market can earn decent value. The market is estimated to be steered by the increased capitalization in the market by stakeholders in the upcoming period. The mounting emphasis on robotic orthopedic implantation surgeries is estimated to empower the market in the forecast period. Technological advancements resulting in sophisticated implants processed from biomaterials can favor the market. Obesity, adventure sports, and sedentary lifestyle that are likely to induce the disease is are generating orthopedic implants market opportunity, especially for revision implants.</p><p>Furthermore, governments funding research and developments for the same can gain momentum for the market. At the same time, developing countries are also observed to open growth scopes for market to surge. However, stringent regulations on the utility of regular orthopedic implants and cost-issues with these implants can impede the market surge. The availability of suitable reimbursement policies to cover bone care expenses can counter the market slow-down.</p><p><strong>Request Free Sample Copy at: </strong><a href="https://www.marketresearchfuture.com/sample_request/838">https://www.marketresearchfuture.com/sample_request/838</a></p><p><strong>Orthopedic Implants Market Segmentation</strong></p><p>The segment assessment for the worldwide orthopedic implants market is done by biomaterial, product type, procedure, device type, end-user, and application.</p><p>· The procedure-based segments of the market are minimally invasive surgery (MIS), and open surgery among others.</p><p>· The device type-based segments of the orthopedic implants market are external fixation devices and internal fixation devices. The external fixation devices segment comprises orthopedic screws, orthopedic rods/wires, fixation pins, orthopedic plates, and orthopedic nails. The external fixation segment can earn high profit for the market.</p><p>· The product type-based segments of the orthopedic implants market are trauma and craniomaxillofacial implants, spinal implants, reconstructive joint implants, dental implants, and Orthobiologics among others</p><p>· The biomaterial-based segments of the orthopedic implants market are ceramic biomaterials, metallic biomaterials, polymer biomaterials, and natural biomaterials.</p><p>· The application-based segments of the market are spine fracture, neck fracture, shoulder replacement, and hip replacement among others.</p><p>· The end-user-based segments of the market are home cares, hospitals, and orthopedic clinics among others.</p><p><strong>Orthopedic Implants Market Regional Analysis</strong></p><p>The regional insight into the orthopedic implants market includes regions such as the Asia Pacific, the Middle East, the Americas, Europe, and Africa. The regional market in the Americas region is projected to control the market due to high financing in orthopedic implants in nations such as the U.S. and Canada, together with the growing undertakings by key players. The European regional market is projected to hold the second principal position in the orthopedic implants market.</p><p>The meticulous activities such as mergers and joint undertakings by many traditional market companies in the European countries is fueling the market growth in this region. The Asia Pacific region is anticipated to be the fastest-growing regional market owing to the growing initiatives by the public and private organizations. Also, increasing acknowledgment of uses of orthopedic implants by patients is backing to the growth of the market in this region. The orthopedic implants market in the Middle East &amp; Africa holds the minimum share of the market owing to the initiatives by public bodies. Furthermore, many businesses are concentrating on these nations so as to expand their target audience.</p><p>Orthopedic Implants Market Players</p><p>· Globus Medical, Inc. (U.S.)</p><p>· Depuy Synthes Inc. (Johnson &amp; Johnson) (U.S.)</p><p>· Smith &amp; Nephew plc. (UK)</p><p>· NuVasive, Inc. (U.S.)</p><p>· Stryker Corporation (U.S.)</p><p>· Integra LifeSciences Holdings Corporation (U.S.)</p><p>· Zimmer Biomet Holdings, Inc. (U.S.)</p><p>· Medtronic, plc (Ireland)</p><p>· Wright Medical Group N.V. (Netherlands)</p><p>· The Orthopedic Implant Company (U.S.)</p><p>· Aesculap Implant Systems (U.S.)</p><p>· Conmed Corporation (U.S.)</p><p>· BioTek Instruments, Inc. (U.S.)</p><p>· Arthrocare Corporation (U.S.)</p><p>among others are some key companies in the global orthopedic implants that are listed by MRFR for market research.</p><p><strong>Browse Detailed TOC with COVID-19 Impact Analysis at: </strong><a href="https://www.marketresearchfuture.com/reports/orthopedic-implant-market-838">https://www.marketresearchfuture.com/reports/orthopedic-implant-market-838</a></p><p><strong>About Market Research Future:</strong></p><p>At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), &amp; Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.</p><p>Contact us:</p><p>Market Research Future (part of Wantstats Research and Media Private Limited),</p><p>99 Hudson Street, 5Th Floor,</p><p>New York, New York 10013</p><p>United States of America</p><p>+1 628 258 0071</p><p>Email: sales@marketresearchfuture.com</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=94a53a429871" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[CBD Market Size is Anticipated to Reach USD 2,207,162 Million at 125.5% CAGR By 2026]]></title>
            <link>https://sandipkumar38491.medium.com/cbd-market-size-is-anticipated-to-reach-usd-2-207-162-million-at-125-5-cagr-by-2026-697753523c0a?source=rss-c5d19b311dc4------2</link>
            <guid isPermaLink="false">https://medium.com/p/697753523c0a</guid>
            <category><![CDATA[cbd]]></category>
            <category><![CDATA[cbd-hemp-oil]]></category>
            <category><![CDATA[cbd-oils]]></category>
            <category><![CDATA[cbd-oil-for-sale]]></category>
            <dc:creator><![CDATA[sandip kumar]]></dc:creator>
            <pubDate>Thu, 16 Sep 2021 16:37:17 GMT</pubDate>
            <atom:updated>2021-09-16T16:37:17.517Z</atom:updated>
            <content:encoded><![CDATA[<h3>CBD Market Overview</h3><p>The <a href="https://www.marketresearchfuture.com/reports/cbd-market-8090">CBD market</a> is predicted to grow at a CAGR of 125.58 per cent to USD 2,207,162.54 million over the forecast period. Cannabidiol (CBD) is a non-addictive, non-psychoactive component of the cannabis plant. After tetrahydrocannabinol, CBD is the second most abundant cannabinoid present in cannabis (THC). CBD possesses anti-inflammatory, anti-anxiety, and seizure-suppressant characteristics, among other therapeutic benefits. CBD was used to treat a medical ailment by about 62% of the population.</p><p>The international market is expected to benefit from increased research &amp; development along with financial support from various private and government organizations for cannabinoid research. CBD is widely available in most parts of the world, while its legal status is still up in the air. CBD’s legal status is likely to change, as there is currently bipartisan agreement to legalize hemp, which would make CBD difficult to prohibit for all intents and purposes.</p><p><strong>Segmental Analysis</strong></p><p>The global CBD market is divided into five categories: form, product, administration route, application, and end-user. By form, the market is further segmented into liquid and solid. By product, the segmentation of the global CBD market is done by food grade and therapeutic grade. By route of administration the market is segmented into capsules, tinctures, and inhalation. By application, the segmentation is done by fibromyalgia, neurodegenerative disorder, protein bars, diabetes and energy drinks. By end-user, the market is segmented into food and beverage and healthcare. By source, the segmentation is done into organic and inorganic.</p><p><strong>Browse More Details at: </strong><a href="https://www.marketresearchfuture.com/reports/cbd-market-8090"><strong>https://www.marketresearchfuture.com/reports/cbd-market-8090</strong></a></p><p><strong>Detailed Regional Analysis</strong></p><p>Due to the growing popularity of cannabis-based goods, the Americas dominate the worldwide CBD market. Marijuana use affects around 2.5% of the world’s population, or about 147 million people every year. Europe has the second-largest market share, owing to a growing understanding of cannabis’ clinical potential. CBD is legal in a number of European countries; therefore, it can be sold publicly. The CBD sector in Europe is booming as a result of such approvals and appraisals by regulatory agencies in the region. The Asia-Pacific region comprises India, Japan, China, and the rest of Asia. Currently, this region is rated third in the market. China has recently passed a law allowing to grow CBD hemp and extract the resulting product. The products are only exported and not sold in China. Chinese businesses’ entry into the industry has created tremendous transformation and growth potential.</p><p><strong>CBD Market Competitive Analysis</strong></p><p>Some of the major companies involved in the global CBD market are Aphria Inc., Freedom Leaf, Green Roads of Florida, CV Sciences, Inc, Canopy Growth Corporation, Elixinol Global Limited, Folium Biosciences, Green Roads of Florida, and ENDOCA. In September 2021, Galaxy Holdings Inc. announced its Genus CBD brand and it has been successfully trademark. It uses VRMS, which is a unique hybrid retailing approach combining the physical attributes of Brick-and-Mortar customer experience, integrating the convenience of the online digital approach.</p><p><strong>Discover more research Reports on </strong><a href="https://www.marketresearchfuture.com/categories/healthcare-market-report">Healthcare Industry</a><strong> by Market Research Future:</strong></p><p><strong>About Market Research Future:</strong></p><p>Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.</p><p>Follow Us: <a href="https://www.linkedin.com/company/market-research-future">LinkedIn</a> | <a href="https://twitter.com/MRFRresearch">Twitter</a></p><p><strong>Contact:</strong></p><p>Market Research Future</p><p>Phone:</p><p>+1 628 258 0071(US)</p><p>+44 2035 002 764(UK)</p><p>Email: <a href="/service/mailto:sales@marketresearchfuture.com">sales@marketresearchfuture.com</a></p><p>Website: <a href="https://www.marketresearchfuture.com/">https://www.marketresearchfuture.com</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=697753523c0a" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Spectral Computed Tomography (CT) Market Share, Dynamics, Outlook And Segmentation | Forecast to…]]></title>
            <link>https://sandipkumar38491.medium.com/spectral-computed-tomography-ct-market-share-dynamics-outlook-and-segmentation-forecast-to-898afd60b47a?source=rss-c5d19b311dc4------2</link>
            <guid isPermaLink="false">https://medium.com/p/898afd60b47a</guid>
            <dc:creator><![CDATA[sandip kumar]]></dc:creator>
            <pubDate>Thu, 24 Jun 2021 16:39:01 GMT</pubDate>
            <atom:updated>2021-06-26T20:11:32.930Z</atom:updated>
            <content:encoded><![CDATA[<h3>Spectral Computed Tomography (CT) Market Share, Dynamics, Outlook And Segmentation | Forecast to 2027</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/200/0*BZwKGqCAVzZ7opon" /></figure><p>The global spectral computed tomography market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East &amp; Africa.</p><p>The Asia-Pacific is expected to hold the largest share of the global spectral computed tomography market. This is owing to the increasing patient population suffering from cancer and cardiovascular diseases and growing geriatric population suffering from numerous diseases are boosting the market growth in this region.</p><p>The Americas market holds the second-largest position in the global spectral computed tomography market owing to the increasing healthcare expenditure, and the presence of large number of medical devices companies in this region.</p><p>Europe is the third-largest region in the global spectral CT market. Factors such as growth in the medical device industry, the presence of developed economies, high per capita disposable income, and increased healthcare spending by consumers are driving the growth of the market in this region.</p><p>The spectral computed tomography market in the Middle East &amp; Africa accounts the least market share due to the adequate healthcare infrastructure support accounted for a relatively smaller market share in 2018.</p><p><strong>Market Highlights</strong></p><p>The<strong> Global </strong><a href="https://www.marketresearchfuture.com/reports/spectral-computed-tomography-market-1026"><strong>Spectral Computed Tomography Market</strong></a><strong> </strong>is expected to register a<strong> CAGR of</strong> <strong>5.8% </strong>during the forecast period with a market value of<strong> USD 969.6 Million till 2025. </strong>Spectral computed tomography (CT) also known as dual-energy CT (DECT) is an advanced form of computed tomography widely used in x-ray scanning technique. Spectral computed tomography is an advanced medical imaging device, which helps in the differentiation and characterization of tissues through the high quality of X-ray images. Spectral computed tomography (CT) contains two different energy spectra to provide concise images on the basis of material density.</p><p>The major key factors driving the market growth are increasing spending on the healthcare IT sector, technological advancements in the diagnostics sector, and increasing demand for diagnostic devices for precise imaging enhances the market growth. Also, the growing prevalence of cardiovascular and neurological diseases across the globe increase the demand for spectral computed tomography (CT) devices. However, factors such as high cost compared to conventional CT scan machines, availability of alternatives CT scan devices, and the less awareness about the products among the radiologists may hamper the market growth.</p><p><strong>Segment Analysis</strong></p><p>The global spectral computed tomography market is segmented into application and end user. On the basis of application, the global spectral computed tomography market has been segmented into oncology, cardiology, musculoskeletal disorders, and gastrointestinal diseases. Based on end user, the market has been segmented into diagnostic centers and hospitals &amp; clinics.</p><p><strong>Access Report Details @ </strong><a href="https://www.marketresearchfuture.com/reports/spectral-computed-tomography-market-1026"><strong>https://www.marketresearchfuture.com/reports/spectral-computed-tomography-market-1026</strong></a> <strong>Market Players</strong></p><p>MRFR recognizes the following companies as the key players in the <strong>global spectral computed tomography market-</strong> <strong>General Electric Company (US), Koninklijke Philips N.V. (Amsterdam, Netherlands), MARS Bioimaging Ltd (Christchurch, New Zealand), Neusoft Corporation (China), Shenzhen Anke High-tech Co., Ltd (China), Siemens (UK), and PerkinElmer Inc. (Waltham, Massachusetts).</strong></p><p><strong>Key Findings of the Study</strong></p><ul><li>The <strong>Global Spectral Computed Tomography Market</strong> was valued at <strong>USD 655.89 million</strong> in <strong>2018</strong>, is estimated to grow at <strong>USD 969.6 million by 2025</strong> at a <strong>CAGR of 5.8%</strong> during the assessment period</li><li>Asia-Pacific accounted for the largest share of the global market due to the presence of key market players and an increasing patient population in Japan, China, and India.</li><li>Based on application, the oncology segment accounted for the largest market share in 2018</li><li>On the basis of the end user, the diagnostic centers dominated the market and accounted for a share of <strong>3 million in 2018</strong></li></ul><p><strong>Browse More Related Reports at:</strong></p><p><a href="https://www.marketresearchfuture.com/reports/chronic-lymphocytic-leukemia-treatment-market-6900">Chronic Lymphocytic Leukemia Treatment Market Size and Share | Forecast to 2027</a></p><p><a href="https://www.marketresearchfuture.com/reports/coronary-stents-market-6938">Global Coronary Stents Market Demand, Size, Share, Growth, Forecast to 2027 | MRFR</a></p><p><a href="https://www.marketresearchfuture.com/reports/adme-toxicology-testing-market-6945">ADME Toxicology Testing Market Size, Share, Trend, Growth, Industry Analysis — Global Forecast to 2027 | MRFR</a></p><p><em>Originally published at </em><a href="https://marketresearchfuturereportr.wordpress.com/2021/06/24/spectral-computed-tomography-ct-market-share-dynamics-outlook-and-segmentation-forecast-to-2027/"><em>http://marketresearchfuturereportr.wordpress.com</em></a><em> on June 24, 2021.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=898afd60b47a" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Insurance Protection Product Market SWOT Analysis, Segmentation and Key Companies Profile |…]]></title>
            <link>https://sandipkumar38491.medium.com/insurance-protection-product-market-swot-analysis-segmentation-and-key-companies-profile-836ed72639b2?source=rss-c5d19b311dc4------2</link>
            <guid isPermaLink="false">https://medium.com/p/836ed72639b2</guid>
            <dc:creator><![CDATA[sandip kumar]]></dc:creator>
            <pubDate>Thu, 24 Jun 2021 16:38:18 GMT</pubDate>
            <atom:updated>2021-06-26T20:14:35.087Z</atom:updated>
            <content:encoded><![CDATA[<h3>Insurance Protection Product Market SWOT Analysis, Segmentation and Key Companies Profile | Forecast to 2027</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/200/0*ZjW8SeUC0KQZQBY6" /></figure><p>Global Insurance Protection Products Market has been segmented based on the Type and Distribution Channel.</p><p>Based on the type, insurance protection products market has been segmented into life insurance, critical issues insurance, income protection insurance, term insurance, long term care insurance, and other insurance. The life insurance segment is further sub-segmented into term life insurance, whole life insurance, universal life insurance, and variable life insurance. The income protection insurance segment is further sub-segmented into disability insurance, long-term disability insurance, disability overhead insurance, total permanent disability insurance, worker’s compensation.</p><p>Based on the distribution channel, the global insurance protection products market has been segmented into direct channel and indirect channel. Because of the advancements in technology, direct channels are mostly used by the insurance companies as they are more convenient for the consumer.</p><p><strong>Key Players</strong></p><p>A few of the key players in the global insurance protection products market are Allianz (Germany), Aviva (UK), Prudential (US), AXA A.S (France), Covea Insurance plc (UK), MetLife Inc. (US), China Life Insurance Company (China), United Health Group Incorporated (US), Aegon Life Insurance Company (India), and Sun Life Financial (Canada).</p><p><strong>Market Highlights</strong></p><p>According to MRFR analysis, the Global <a href="https://www.marketresearchfuture.com/reports/insurance-protection-product-market-9984">Insurance Protection Products Market</a> is expected to register an <strong>8.6% CAGR</strong> during the forecast period, 2020 to 2027, and reach <strong>USD 154.10 Billion by 2027</strong>.</p><p>Insurance policy is a contract between the insurer and the insuree to pay the subsequent amount for the losses the insuree has faced. Insurance policy can be taken for life, retirement policy, car insurance, mobile insurance, or fire insurance, among others. The insurance company pools the client’s risks to make payments more affordable for the insured.</p><p>The rapid spread of COVID-19 and the increasing instances of life-threatening diseases, including heart-related diseases, are driving the demand for policies across the world. The US is the world’s largest market for insurance protection products, followed by China and Japan. Insurance companies offer a wide selection of policies for insuring every entity owned by a person.</p><p>Furthermore, AI, blockchain, digitization, and personalization, as well as hiring and retaining technically skilled talent, are increasing the demand for insurance worldwide. The increasing use of IoT-enabled devices such as sensors and radio frequency identification (RFIDs) has increased the amount of data that can be monitored to generate meaningful insights. Increasing testing and awareness of chronic diseases is creating lucrative opportunities for the growth of the insurance protection products market during the forecast period.</p><p>However, the increasing competition, availability of various substitutes of companies, and reimbursement for COVID-19 cases are expected to restrain the growth of the global insurance protection products market during the study period.</p><p>Some of the key players, such as Aviva Insurance has introduced a strategy known as simplicity wins- renewal agenda 2.0. Aviva, Prudential, and other companies based in the US and the UK have a benefit of providing income protection insurance as these policies are offered in only a few countries. It is compulsory for citizens in the US to have an insurance policy for life and car, which eventually helps the insurance companies to increase the revenue.</p><p><strong>Regional Analysis</strong></p><p>The insurance protection products market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East &amp; Africa.</p><p>The Americas held the largest market in 2019, owing to the rising demand for insurance policies in the region due to the increase in chronic diseases and governmental restrictions. The insurance protection products market in the Americas has further been sub-segmented into North America and Latin America, with North America divided into the US and Canada.</p><p><strong>Browse Full Report Details @ </strong><a href="https://www.marketresearchfuture.com/reports/insurance-protection-product-market-9984"><strong>https://www.marketresearchfuture.com/reports/insurance-protection-product-market-9984</strong></a></p><p>The European insurance protection products market has been categorized into Western Europe and Eastern Europe. Western Europe has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.</p><p>The insurance protection products market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing rate of chronic diseases and awareness among people and the latest technology, the market in the region is expected to be the fastest-growing regional market during the forecast period.</p><p>The insurance protection products market in the Middle East &amp; Africa has been divided into the Middle East and Africa.</p><p><strong>Browse More Related Reports at:</strong></p><p><a href="https://www.marketresearchfuture.com/reports/cell-cycle-analysis-market-673">Cell Cycle Analysis Market Overview, Size, Growth, Industry Forecast to 2027</a></p><p><a href="https://www.marketresearchfuture.com/reports/global-prescribed-health-apps-market-758">Prescribed Health apps Market Growth By Devices, Size and Trend Forecast To 2024</a></p><p><a href="https://www.marketresearchfuture.com/reports/robotic-flight-simulator-surgery-market-996">Robotic Flight Simulator Surgery Market Report- 2027 | MRFR</a></p><p><em>Originally published at </em><a href="https://marketresearchfuturereportr.wordpress.com/2021/06/24/insurance-protection-product-market-swot-analysis-segmentation-and-key-companies-profile-forecast-to-2027/"><em>http://marketresearchfuturereportr.wordpress.com</em></a><em> on June 24, 2021.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=836ed72639b2" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Life Science and Analytical Instruments Market Key Companies Profile, Size and Share Till 2027]]></title>
            <link>https://sandipkumar38491.medium.com/life-science-and-analytical-instruments-market-key-companies-profile-size-and-share-till-2027-e661a76652e0?source=rss-c5d19b311dc4------2</link>
            <guid isPermaLink="false">https://medium.com/p/e661a76652e0</guid>
            <dc:creator><![CDATA[sandip kumar]]></dc:creator>
            <pubDate>Thu, 24 Jun 2021 16:38:04 GMT</pubDate>
            <atom:updated>2021-06-26T20:13:27.092Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/200/0*yBFLh-ZpE4Ak5lzT" /></figure><p>Region-wise, the global life science and analytical instruments market is distributed into Asia Pacific, Europe, North America, and the Rest-of-the-World.</p><p>The North America region witnesses a vast development in drug discovery research, along with an increasing number of research studies, and expansion of industrial sector, leading to its leading position in the global life science &amp; analytical instruments market. In addition, other factors such as the presence of well-known players alongside the growing focus in the field of research for the life science products propel the market growth in the region. furthermore, the rapid pace of advancements in technologies in the region provide the region an edge over other regions. The United States (US) backed by massive investments in the life science &amp; analytical instruments will lead the regional market in the coming years.</p><p>The Europe region has acquired the second position in the global life science &amp; analytical instruments market, as a result of the accelerated demand for the life science products. This demand comes predominately from the expanding pharmaceutical sector in the region, catapulting the growth of the life science &amp; analytical instruments market in the region.</p><p>The Asia Pacific region witness major growth in the market with the high uptake of advanced technology. Moreover, the market provides several growth opportunities with the increasing clinical research along with growing government support. Apart from this, the increasing number of testing laboratories and developing agricultural industries are supporting the growth of the regional market as well.</p><p><strong>Market Overview</strong></p><p>As per the new report furnished by Market Research Future (MRFR), the global <a href="https://www.marketresearchfuture.com/reports/life-science-analytical-instruments-market-825">life science and analytical instruments market</a>, in 2016, was worth the value of USD 36.5 billion and will be attaining the valuation of USD 56.7 billion by the end of 2023. Furthermore, the market will be soaring high at a CAGR of 6.5 % during the forecast period (2017–2023).</p><p><strong>Market Drivers and Challenges</strong></p><p>The past couple of years have been quite eventful for instrument companies, characterized by major mergers and acquisitions, new product launches, partnerships, as well as other business developments. With growing government spending on pharmaceutical research and development (R&amp;D) activities in emerging economies, technological advancements, elevated drug discovery and clinical diagnostics field, increasing life science research and development expenditure, and emergence of various applications, the market will most definitely garner massive revenue during the review period.</p><p>Moreover, expanding aging populations, in addition to the increasing prevalence of chronic diseases, and changing demographics and also several industry participants reporting record sales have also been responsible for the strong growth of the market. Developing nations like India, China, and Brazil are showing highly lucrative market expansion. In contrast, the availability of alternative technologies and high cost of instruments could hinder the growth of the market to some extent.</p><p>However, the ever-growing list of drivers such as the increasing number of biotechnology firms globally, advances in life science research and technology innovations involving human genome mapping, and emergence of proteomics have resulted in the industry growth. These factors have led to high-end research projects which need quality instruments with high throughput capacity, thus elevating the market position of life Science and analytical instrumentation.</p><p><strong>Market Segmentation</strong></p><p>The market for life science and analytical instruments is segmented on the basis of type, end-user and application.</p><p>The type-wise segmentation has been done on the basis of Centrifuges (Laboratory centrifuges, Analytical ultracentrifuges, Gas centrifuges and Other), Chromatography (Thin-layer Chromatography (TLC), Liquid Chromatography, Gas Chromatography, HPTLC and Other), Electrophoresis (Conventional Electrophoresis [One Dimensional and two dimensional) and Capillary Electrophoresis), Flow Cytometry, Microscopy (Scanning electron microscope, Transmission electron microscope and Other), Cell Counting instruments (Hemocytometers and Other), PCR, Spectroscopy (Mass Spectroscopy, UV spectroscopy, Atomic spectroscopy and Other), Western Blotting, Other (Sterilization instruments, Incubators, Colorimeters, Freezers, Laboratories balances, other).</p><p>The end-users in the global market include Pharmaceutical and Biotechnology Companies, Agriculture and Food Industry, Research and Clinical Testing Laboratories and Other.</p><p>Application-wise, the market caters to research applications, diagnostic applications and others.</p><p><strong>Browse Complete Report @ </strong><a href="https://www.marketresearchfuture.com/reports/life-science-analytical-instruments-market-825"><strong>https://www.marketresearchfuture.com/reports/life-science-analytical-instruments-market-825</strong></a> <strong>Key Vendors</strong></p><p>The key vendors competing in the global life science and analytical instrumentation market are Avance Biosciences (US), Becton, Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Dickinson and Company (U.S.), Danaher Corporation (U.S), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), Waters Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Bruker Corporation (U.S.), Paragon Bioservices, Inc (US), Dynalabs (US) Shimadzu Corporation (Japan), Avista Pharma Solutions(US), Merck KGaA (Germany) among others.</p><p><strong>Latest Developments</strong></p><p>Agilent Technologies Inc. (the US), a public research, development, and manufacturing company announced its expansion in the financial capital of India — Mumbai by inaugurating its third Centre of Excellence (CoE). The state-of-the-art laboratory is equipped with Agilent’s new products, chemistries, and software, providing a wide range of application support to life science and applied markets.</p><p><strong>Browse More Related Reports at:</strong></p><p><a href="https://www.marketresearchfuture.com/reports/telehealth-market-900">Telehealth Market Trends, Size, Growth, Share, Application and Analysis by 2024 | MRFR</a></p><p><a href="https://www.marketresearchfuture.com/reports/migraine-drugs-market-8379">Migraine Drugs Market by Type, Drug Class, Growth Analysis Till 2027 | MRFR</a></p><p><a href="https://www.marketresearchfuture.com/reports/patient-registry-software-market-6917">Patient Registry Software Market Size, Share, Type, Global Analysis, 2027 | MRFR</a></p><p><em>Originally published at </em><a href="https://marketresearchfuturereportr.wordpress.com/2021/06/24/life-science-and-analytical-instruments-market-key-companies-profile-size-and-share-till-2027/"><em>http://marketresearchfuturereportr.wordpress.com</em></a><em> on June 24, 2021.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e661a76652e0" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Osteosarcoma Market Insights, Sales, Cost and Profit | Forecast to 2027]]></title>
            <link>https://sandipkumar38491.medium.com/osteosarcoma-market-insights-sales-cost-and-profit-forecast-to-2027-857394e2f897?source=rss-c5d19b311dc4------2</link>
            <guid isPermaLink="false">https://medium.com/p/857394e2f897</guid>
            <dc:creator><![CDATA[sandip kumar]]></dc:creator>
            <pubDate>Thu, 24 Jun 2021 16:38:03 GMT</pubDate>
            <atom:updated>2021-06-26T20:12:53.336Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/200/0*3BgZLjWterJpFAh4" /></figure><p>The Global Osteosarcoma Market has been segmented into type, diagnosis &amp; treatment, end user, and region.</p><p>Based on type, the global osteosarcoma market has been segmented into intramedullary osteosarcoma, juxtacortical osteosarcoma, and extraskeletal osteosarcoma. On the basis of diagnosis &amp; treatment, the global osteosarcoma market has been segregated into treatment and diagnosis. The treatment segment is further segmented into chemotherapy, surgery, radiation therapy, and others. The chemotherapy segment includes cisplatin, doxorubicin, epirubicin, and others. The surgery segment includes limb-sparing surgery and amputation.</p><p>The diagnosis segment is further segmented into imaging, biopsies, and blood tests. The imaging segment includes computerized tomography (CT), magnetic resonance imaging (MRI), X-Ray, positron emission tomography (PET) and others. The biopsies segment includes needle biopsy and surgical biopsy. The blood tests segment includes alkaline phosphatase profiling, lactate dehydrogenase profiling, and others.</p><p>On the basis of end-user, the global osteosarcoma market has been segmented into hospitals &amp; clinics, diagnostic centers, and academic &amp; research organizations.</p><p><strong>Access Report Details @ Market Players</strong> <a href="https://www.marketresearchfuture.com/reports/osteosarcoma-market-4412"><strong>https://www.marketresearchfuture.com/reports/osteosarcoma-market-4412</strong></a> <strong>Regional Analysis</strong></p><p>Market Research Future (MRFR) recognizes are <strong>Pfizer Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Baxter, Novartis AG, Aurobindo Pharma, Hikma Pharmaceuticals PLC, Mylan N.V., and ADVAXIS, INC. </strong>as the key players in the Global Osteosarcoma Market.</p><p><strong>Market Highlights</strong></p><p>The Osteosarcoma market in the Americas has been segmented into North America and Latin America. The North American market has been further divided into the US and Canada. The Americas dominate the global Osteosarcoma market, owing to the rising incidence of cancer. According to an article published in the North American Association of Central Cancer Registries, about 3,809 incident cases of osteosarcoma were identified in patients aged 40 years or older in <strong>2018</strong>.</p><p><a href="https://www.marketresearchfuture.com/reports/osteosarcoma-market-4412"><strong>Osteosarcoma Market</strong></a><strong> </strong>is estimated to be valued at <strong>USD 791.08 Million by 2025 </strong>and is expected to register a<strong> CAGR of 6.09% </strong>during the forecast period.</p><p>The Global Osteosarcoma Market was valued at <strong>USD 522.20 Million in 2018</strong>, and the market is estimated to grow to <strong>USD 791.08 Million by 2025</strong> and is expected to register a <strong>CAGR of 6.09%</strong> during the forecast period from <strong>2019 to 2025</strong>. <strong>In</strong> <strong>2018</strong>, the Americas accounted for the largest market share of <strong>40.02%,</strong> with a market value of <strong>USD 6,103.30 million</strong>, followed by Europe.</p><p><strong>Key Findings of the Study:</strong></p><p>Based on type, the intramedullary osteosarcoma segment accounted for the largest market share of <strong>80.30% in 2018</strong>, is projected to register a <strong>CAGR of 6.25%</strong> during the forecast period. On the basis of diagnosis &amp; treatment, the treatment segment accounted for the largest market share of <strong>85.32%</strong> in <strong>2018</strong>, is projected to register a <strong>CAGR of 6.26%</strong> during the forecast period.</p><ul><li>The <strong>Global Osteosarcoma Market</strong> is projected to reach over <strong>USD 791.08 Million by 2025</strong> at a <strong>09% CAGR</strong> during the review period of <strong>2019 to 2025</strong>.</li><li>Americas accounted for the largest market share, with the US being the major contributor to the growth of the market.</li><li>By end-user, hospitals &amp; clinics segment is projected to register the largest market share of <strong>37%</strong> during the forecast period. Its largest market share can be attributed to an increase in the number of patients who have cancer, coupled with a rise in a number of hospitals, and quality care, and availability of skilled and qualified professionals.</li><li>Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies.</li></ul><p><strong>Browse More Related Reports at:</strong></p><p><a href="https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470">Medical Marijuana Market Statistics | Global Industry Size, Growth, And Forecast To 2027</a></p><p><a href="https://www.marketresearchfuture.com/reports/car-t-cell-therapy-market-8102">CAR T Cell Therapy Market Size, Share, &amp; Trends Analysis | Forecast to 2027</a></p><p><a href="https://www.marketresearchfuture.com/reports/healthcare-artificial-intelligence-market-5681">Healthcare Artificial Intelligence (AI) Market Size, Global Report, Trends, Industry Analysis by 2027</a></p><p><em>Originally published at </em><a href="https://marketresearchfuturereportr.wordpress.com/2021/06/24/osteosarcoma-market-insights-sales-cost-and-profit-forecast-to-2027/"><em>http://marketresearchfuturereportr.wordpress.com</em></a><em> on June 24, 2021.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=857394e2f897" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>